TOG Review (RCOG Journal)
MRCOG Part 2
Gynaecological Oncology
Human papillomavirus-independent cervical cancer and its precursor lesions
Key Statistics
- 5–11% — Cervical cancers HPV-negative
- 54% — 5-Yr survival, GAC
- 42% vs 91% — 5-Yr DSS: GAC vs HPV+ AdenoCa
Don't-miss facts
-
5–11% of cervical cancers are HPV-negative on testing – NOT automatically HPV-independent; false negatives occur due to test target loss, low viral load, sampling error, or assay type
-
Gastric spectrum: LEGH/PGM (benign) → atypical LEGH/GAIS (premalignant) → GAC (malignant); GAC = majority of HPV-independent adenocarcinoma
-
Red-flag features: profuse watery mucoid discharge, abnormal uterine bleeding, abdominal pain, bulky indurated cervix, multicystic lesion on MRI – assess even if HPV test negative
-
MRI ‘cosmos pattern’ = highly specific for LEGH; GAC shows solid-cystic components, deep infiltration, restricted diffusion
-
Peutz–Jeghers syndrome (STK11 mutation) → increased LEGH/GAC risk – needs regular surveillance
-
GAC 5-year disease-specific survival 42% vs 91% for HPV-associated adenocarcinoma (Karamurzin et al.)
-
GAC IHC: PAX8+, p16 negative/mosaic, p53 aberrant in ~52%, HNF-1 positive ~90% (can mimic clear cell carcinoma)
-
Confirmed GAC: manage as HPV-associated cancer but lower threshold for pelvic lymph node assessment (incl. sentinel node mapping) due to higher LVSI/nodal metastasis risk
Figure – WHO 2020 classification logic
Cervical carcinoma
HPV-associated HPV-independent
SCC · usual-type AIS/AdenoCa
Gastric-type Clear cell Mesonephric LEGH → atypical 3–4% of <1% of LEGH/GAIS → GAC AdenoCa AdenoCa
- NOS adenocarcinoma; + rare HPV-independent SCC (5–7% of cervical SCC)
AIS preinvasive glandular lesion classified by HPV status; preinvasive squamous lesions remain a single HPV-associated category
Simplified WHO 2020 classification logic for cervical carcinoma by HPV association.
AdenoCa = adenocarcinoma; AIS = adenocarcinoma in situ; GAC = gastric adenocarcinoma; GAIS = gastric adenocarcinoma in situ; LEGH = lobular endocervical glandular hyperplasia; NOS = not otherwise specified; SCC = squamous cell carcinoma. PRECURSOR SPECTRUM & SURVIVAL
Benign: LEGH/PGM (5-yr survival 100%) Malignant: GAC (5-yr survival 54%; DSS 42%)
Abbreviation Key
- HPV — human papillomavirus
- IECC — International Endocervical Adenocarcinoma Criteria and Classification
- WHO — World Health Organization
- MRI — magnetic resonance imaging
- GAC — gastric-type adenocarcinoma
- FIGO — International Federation of Gynecology and Obstetrics
- GAIS — gastric adenocarcinoma in situ
- PAS — periodic acid Schiff
- LEGH — lobular endocervical glandular hyperplasia
- CEA — carcinoembryonic antigen
- PGM — pyloric gland metaplasia
- MMR — mismatch repair
- AIS — adenocarcinoma in situ
- PD-L1 — programmed death-ligand 1
- MDA — minimal deviation adenocarcinoma
- DSS — disease-specific survival
- NOS — not otherwise specified
Source: Aggarwal IM, Yeo YC, Ng ZY. Human papillomavirus-independent cervical cancer and its precursor lesions. The Obstetrician & Gynaecologist 2023;25:47–58. doi:10.1111/tog.12855
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).